1. Home
  2. TECX vs XMAX Comparison

TECX vs XMAX Comparison

Compare TECX & XMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$19.69

Market Cap

618.9M

Sector

N/A

ML Signal

N/A

Logo XMAX Inc. Common Stock

XMAX

XMAX Inc. Common Stock

N/A

Current Price

$6.55

Market Cap

529.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
XMAX
Founded
2019
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
529.8M
IPO Year
2018
2009

Fundamental Metrics

Financial Performance
Metric
TECX
XMAX
Price
$19.69
$6.55
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $71.00
N/A
AVG Volume (30 Days)
182.1K
★ 723.5K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.70
★ 88.51
EPS
N/A
★ 0.62
Revenue
N/A
★ $12,744,871.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$13.17
Revenue Growth
★ N/A
N/A
52 Week Low
$15.60
$8.06
52 Week High
$39.53
$9.40

Technical Indicators

Market Signals
Indicator
TECX
XMAX
Relative Strength Index (RSI) 30.40 20.38
Support Level $16.77 N/A
Resistance Level $22.44 $9.16
Average True Range (ATR) 1.08 0.42
MACD 0.16 -0.14
Stochastic Oscillator 4.51 4.56

Price Performance

Historical Comparison
TECX
XMAX

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About XMAX XMAX Inc. Common Stock

XMax Inc is a designer and lifestyle furniture company. The company is a designer and distributor of contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. The company plans expansion into artificial intelligence (AI) while continuing to operate and develop its existing furniture business.

Share on Social Networks: